Bloomberg -- Migraine headache medicines, including GlaxoSmithKline Plc’s Imitrex and Merck & Co.'s Maxalt, caused potentially fatal reactions in at least 11 people, according to today’s New England Journal of Medicine.
Bloomberg -- Migraine headache medicines, including GlaxoSmithKline Plc’s Imitrex and Merck & Co.'s Maxalt, caused potentially fatal reactions in at least 11 people, according to today’s New England Journal of Medicine.